Home Science Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease
Science - January 9, 2025

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease

Largest DxA investment to date supports development of Alamar’s ARGO™ DX System and future in vitro diagnostic tests 

cancer

Author Of article :

Read full article

Leave a Reply

Your email address will not be published. Required fields are marked *

1 × five =

Check Also

MoMath Brings Prime Numbers to a Prime New Location

After outgrowing its original home, the National Museum of Mathematics has added new exhib…